RBMX在食管鳞状细胞癌中的相关性研究——RBMX对食管鳞状细胞癌细胞增殖和凋亡的影响
Study on the Correlation of RBMX in Esophageal Squamous Cell Carcinoma—Effects of RBMX on the Proliferation and Apoptosis of Esophageal Squamous Cell Carcinoma
DOI: 10.12677/BP.2021.113007, PDF,    国家自然科学基金支持
作者: 刘 芳:南通大学,江苏省神经再生教育部重点实验室,江苏 南通;南通大学,神经再生协同创新中心,江苏 南通;南通大学,医学院,江苏 南通;李贵才:南通大学,江苏省神经再生教育部重点实验室,江苏 南通;南通大学,神经再生协同创新中心,江苏 南通;丁宗梅:苏北人民医院,病理科,江苏 扬州;秦 凯, 陆松华*:南通大学附属海安医院,胸外科,江苏 海安
关键词: 食管鳞状细胞癌RBMX细胞增殖细胞凋亡 Esophageal Squamous Cell Carcinoma RBMX Cell Proliferation Cell Apoptosis
摘要: RBMX (也称为hnRNP G)是hnRNP家族的成员,最早被鉴定为表观分子量为43 kDa的核蛋白。本研究目的主要是检验RBMX在ESCC中是否是肿瘤抑制因子的假设。对食管鳞状细胞癌组织进行免疫组织化学和蛋白质印迹分析。采用Kaplan-Meier法来分析ESCC患者的生存率。通过构建RBMX的过表达质粒,研究了RBMX在TE1食管鳞状细胞癌细胞系增殖中的作用。通过CCK-8和流式细胞术测定RBMX对增殖和凋亡的调节。免疫组化分析显示RBMX表达与Ki67呈负相关。生存分析显示RBMX表达与总体生存率显著相关(P < 0.001)。RBMX在TE1细胞中的过表达可导致CyclinD1 (细胞周期蛋白D1)、CDK4和p27水平降低和细胞增殖能力的下降。此外,RBMX的过表达可以诱导TE1细胞凋亡。这些发现表明RBMX参与了食管鳞状细胞癌的增殖,并且RBMX表达水平的升高可能表示食管鳞状细胞癌患者的良好预后。
Abstract: RBMX (also known as hnRNP G), is a member of hnRNP family and was first identified as a nuclear protein with an apparent molecular weight of 43 kDa. The current study was designed to test the hypothesis that RBMX is a tumor suppressor. Immunohistochemical and western blot analyses were performed in esophageal squamous cell carcinoma tissues. Survival analyses were performed by using the Kaplan-Meier method. The role of RBMX in proliferation was studied in esophageal squamous cell carcinoma cell lines of TE1 by constructing the RBMX overexpression plasmid. The regulation of RBMX on proliferation and apoptosis was determined by Cell Counting Kit-8 assays and Flow Cytometry. Immunohistochemical analysis showed that RBMX expression was negatively associated with Ki67. Survival analysis revealed that RBMX expression was significantly associated with overall survival (P < 0.001). Over-expression of RBMX in TE1 cells resulted in decreased CyclinD1, CDK4 and p27 levels and the capability for proliferation. In addition, over-expression of RBMX induces the Apoptosis of TE1 cells. These findings suggest that RBMX is involved in the proliferation of esophageal squamous cell carcinoma, and that elevated levels of RBMX expression may indicate a good prognosis for patients with esophageal squamous cell carcinoma.
文章引用:刘芳, 李贵才, 丁宗梅, 秦凯, 陆松华. RBMX在食管鳞状细胞癌中的相关性研究——RBMX对食管鳞状细胞癌细胞增殖和凋亡的影响[J]. 生物过程, 2021, 11(3): 54-65. https://doi.org/10.12677/BP.2021.113007

参考文献

[1] Ferlay, J., Soerjomataram, I., Dikshit, R., et al. (2015) Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012. International Journal of Cancer, 136, E359-E386. https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ijc.29210?download=true [Google Scholar] [CrossRef] [PubMed]
[2] Fan, J.H., Liu, Z.Q., Mao, X.H., et al. (2020) Global Trends in the Incidence and Mortality of Esophageal Cancer from 1990 to 2017. Cancer Medicine, 9, 6875-6887. [Google Scholar] [CrossRef] [PubMed]
[3] Tong, Y., Yang, L., Yu, C., et al. (2020) Tumor-Secreted Exosomal lncRNA POU3F3 Promotes Cisplatin Resistance in ESCC by Inducing Fibroblast Differentiation into CAFs. Molecular Therapy—Oncolytics, 18, 1-13. https://www.ncbi.nlm.nih.gov/pubmed/32637576 [Google Scholar] [CrossRef] [PubMed]
[4] Kang, M., Ren, M., Li, Y., et al. (2018) Exosome-Mediated Transfer of lncRNA PART1 Induces Gefitinib Resistance in Esophageal Squamous Cell Carcinoma via Functioning as a Competing Endogenous RNA. Journal of Experimental & Clinical Cancer Research, 37, 171. https://www.ncbi.nlm.nih.gov/pubmed/30049286 [Google Scholar] [CrossRef] [PubMed]
[5] Yu, J., Wang, W., Yao, W., et al. (2020) Gambogic Acid Affects ESCC Progression through Regulation of PI3K/AKT/mTOR Signal Pathway. Journal of Cancer, 11, 5568-5577. https://www.ncbi.nlm.nih.gov/pubmed/32913452 [Google Scholar] [CrossRef] [PubMed]
[6] Wang, M., Hao, C., Ma, Q., et al. (2016) DNA Image Cy-tometry Test for Primary Screening of Esophageal Cancer: A Population-Based Multi-Center Study in High-Risk Areas in China. Chinese Journal of Cancer Research, 28, 404-412. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=27647968 [Google Scholar] [CrossRef] [PubMed]
[7] Sohda, M. and Kuwano, H. (2017) Current Status and Future Prospects for Esophageal Cancer Treatment. Annals of Thoracic and Cardiovascular Surgery, 23, 1-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=28003586 [Google Scholar] [CrossRef] [PubMed]
[8] Pennathur, A., Gibson, M.K., Jobe, B.A. and Luketich, J.D. (2013) Oesophageal Carcinoma. The Lancet, 381, 400-412. [Google Scholar] [CrossRef
[9] Chaudhuri, A., Das, S. and Das, B. (2020) Locali-zation Elements and Zip Codes in the Intracellular Transport and Localization of Messenger RNAs in Saccharomyces cerevisiae. Wiley Interdisciplinary Reviews: RNA, 11, e1591.
https://www.ncbi.nlm.nih.gov/pubmed/32101377
[10] Soulard, M., Della Valle, V., Siomi, M.C., et al. (1993) hnRNP G: Sequence and Characterization of a Glycosylated RNA-Binding Protein. Nucleic Acids Research, 21, 4210-4217. https://www.ncbi.nlm.nih.gov/pubmed/7692398 [Google Scholar] [CrossRef] [PubMed]
[11] Delbridge, M.L., Lingenfelter, P.A., Disteche, C.M. and Graves, J.A. (1999) The Candidate Spermatogenesis Gene RBMY Has a Homologue on the Human X Chromosome. Nature Genetics, 22, 223-224. https://www.ncbi.nlm.nih.gov/pubmed/10391206 [Google Scholar] [CrossRef] [PubMed]
[12] Mazeyrat, S., Saut, N., Mattei, M.G. and Mitchell, M.J. (1999) RBMY Evolved on the Y Chromosome from a Ubiquitously Transcribed X-Y Identical Gene. Nature Genetics, 22, 224-226. https://www.ncbi.nlm.nih.gov/pubmed/10391207 [Google Scholar] [CrossRef] [PubMed]
[13] Song, Y., He, S., Ma, X., et al. (2020) RBMX Contributes to Hepatocellular Carcinoma Progression and Sorafenib Resistance by Specifically Binding and Stabilizing BLACAT1. American Journal of Cancer Research, 10, 3644-3665.
https://www.ncbi.nlm.nih.gov/pubmed/33294259
[14] Shin, K.H., Kang, M.K., Kim, R.H., et al. (2006) Hetero-geneous Nuclear Ribonucleoprotein G Shows Tumor Suppressive Effect against Oral Squamous Cell Carcinoma Cells. Clinical Cancer Research, 12, 3222-3228. https://www.ncbi.nlm.nih.gov/pubmed/16707624 [Google Scholar] [CrossRef
[15] Shin, K.H., Kang, M.K. and Park, N.H. (2008) Heteroge-neous Nuclear Ribonucleoprotein G, Nitric Oxide, and Oral Carcinogenesis. Nitric Oxide, 19, 125-132. https://www.ncbi.nlm.nih.gov/pubmed/18474262 [Google Scholar] [CrossRef] [PubMed]
[16] Sutherland, L.C., Rintala-Maki, N.D., White, R.D. and Morin, C.D. (2005) RNA Binding Motif (RBM) Proteins: A Novel Family of Apoptosis Modulators? Journal of Cellular Biochem-istry, 94, 5-24.
https://www.ncbi.nlm.nih.gov/pubmed/15514923
[17] Pimenta, A.L., Di Martino, P. and Blight, M.A. (2006) Positive Correlation between in Vivo and in Vitro Assays for the Evaluation of Pseudomonas virulence. Research in Mi-crobiology, 157, 885-890. https://www.ncbi.nlm.nih.gov/pubmed/16901681 [Google Scholar] [CrossRef] [PubMed]
[18] Martinez-Arribas, F., Agudo, D., Pollan, M., et al. (2006) Posi-tive Correlation between the Expression of X-Chromosome RBM Genes (RBMX, RBM3, RBM10) and the Proapoptotic Bax Gene in Human Breast Cancer. Journal of Cellular Biochemistry, 97, 1275-1282.
https://www.ncbi.nlm.nih.gov/pubmed/16552754
[19] Shin, K.H., Kim, R.H., Kang, M.K., et al. (2007) p53 Pro-motes the Fidelity of DNA End-Joining Activity by, in Part, Enhancing the Expression of Heterogeneous Nuclear Ribo-nucleoprotein G. DNA Repair (Amst), 6, 830-840. https://www.ncbi.nlm.nih.gov/pubmed/17387044 [Google Scholar] [CrossRef] [PubMed]
[20] Shin, K.H., Kim, R.H., Yu, B., et al. (2011) Expression and Mutation Analysis of Heterogeneous Nuclear Ribonucleoprotein G in Human Oral Cancer. Oral Oncology, 47, 1011-1016.
https://www.ncbi.nlm.nih.gov/pubmed/21840245
[21] Knudsen, K.E., Diehl, J.A., Haiman, C.A. and Knudsen, E.S. (2006) Cyclin D1: Polymorphism, Aberrant Splicing and Cancer Risk. Oncogene, 25, 1620-1628. https://www.ncbi.nlm.nih.gov/pubmed/16550162 [Google Scholar] [CrossRef] [PubMed]
[22] Shan, Y.S., Hsu, H.P., Lai, M.D., et al. (2017) Cyclin D1 Overex-pression Correlates with Poor Tumor Differentiation and Prognosis in Gastric Cancer. Oncology Letters, 14, 4517-4526. https://www.ncbi.nlm.nih.gov/pubmed/28943959 [Google Scholar] [CrossRef] [PubMed]
[23] Radenkovic, S., Konjevic, G., Nikitovic, M., et al. (2021) Evaluation of Cyclin D1 Expression by Western Blotting Methods and Immunohistochemistry in Breast Cancer Patients. Journal of BUON, 26, 475-482.
https://www.ncbi.nlm.nih.gov/pubmed/34076995
[24] Cheng, G., Zhang, L.M., Lv, W.Y., et al. (2015) Overex-pression of Cyclin D1 in Meningioma Is Associated with Malignancy Grade and Causes Abnormalities in Apoptosis, Invasion and Cell Cycle Progression. Medical Oncology, 32, 439. [Google Scholar] [CrossRef] [PubMed]
[25] Jain, A.K., Allton, K., Iacovino, M., et al. (2012) p53 Regulates Cell Cycle and microRNAs to Promote Differentiation of Human Embryonic Stem Cells. PLOS Biology, 10, e1001268. https://www.ncbi.nlm.nih.gov/pubmed/22389628 [Google Scholar] [CrossRef] [PubMed]